Getting to 95-95-95: global use of HIV generics would result in large reductions in spending, new infections and deaths
Generic HIV combination medications, such as tenofovir/lamivudine/dolutegravir (TDF/3TC/DTG), could be produced for as little as $ 59 per person per year. Achieving the 95-95-95 targets based on this cost could result each year in $ 26 billion being saved, 630,000 fewer new HIV infections and 240,000 fewer deaths, according to a recent study by Dr… Read More »